arsenic trioxide has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farmer, I; Gupta, S; Kulasekararaj, AG; Littlewood, S; Moonim, M; Okikiolu, J; Oram, SH; Steel, M; Thanigaikumar, M; Wanniarachchi, C; Yeghen, T | 1 |
1 other study(ies) available for arsenic trioxide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; COVID-19; COVID-19 Drug Treatment; Humans; Leukemia, Promyelocytic, Acute; Male; SARS-CoV-2; Tretinoin | 2020 |